Dexcom Inc. received U.S. FDA clearance for its Smart Basal CGM-integrated basal insulin dosing optimizer. Designed for adults with type 2 diabetes using glargine U-100 long-acting insulin therapy, ...
A recent internet report claimed that during a meeting, the U.S. President suggested stopping hurricanes with nuclear weapons ...
Share your thoughts and join the conversation in the comments.
OANDA examines how Western sanctions against Russia failed to achieve total economic collapse and accelerating global ...
Canada has also moved relatively quickly to elevate diplomatic and economic ties with Saudi Arabia. Earlier this month, ...
The burden of guaranteeing the future reparations loan for Ukraine should be shared not only by European countries but also ...
Despite President Erdogan’s continued assault on Turkish democracy, Europe is still interested in bringing the country into the union.
Annual price rises help businesses to protect their profits in uncertain times – but could be driving inflation.
The race to mine rare earth elements in Canada is on. But Mary-Lou Harley, an activist with a PhD in chemistry, says ...
Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer.
Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. | Dexcom said Smart Basal is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback